Research Grants 25 show all


$902.3K
2009

$1.3M
2010

$3.5M
2011

$289.5K
2012

$150K
2015

Patents 117show all

  • 60
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 28
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 22
    C07K - Peptides
  • 8
    A61K - Preparations for medical, dental, or toilet purposes
  • 1
    C07C - Acyclic or carbocyclic compounds
  • 1
    C07D - Heterocyclic compounds
  • 1
    E02F - Dredging
  • 1
    G01B - Measuring length, thickness or similar linear dimensions
  • 1
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 1
    G16Z - Information and communication technology [ict] specially adapted for specific application fields, not otherwise provided for

Clinical Trials 9show all

SEC Filings show all


6
D

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2015-03-18$5,000,000$1,808,145Equity
2014-02-25$1,999,999$1,999,999Equity
2013-07-31$5,999,998$5,999,998Equity

Key Executives

  • Jackson Streeter, M.D.
    Executive Officer, Director
  • Ronald Hayes, Ph.D.
    Executive Officer, Director
  • Steven Richieri
    Executive Officer
  • Luis De Taboada
    Executive Officer
  • Julie Pashkowsky
    Executive Officer
  • Tony Grover
    Executive Officer
  • Henry Nordhoff
    Director
  • Andrew von Eschenbach, M.D.
    Director
  • Stanford Warshawsky
    Director
  • Nancy Denslow, Ph.D.
    Director
  • David Flagg
    Director
  • William Roper, Jr.
    Director